View Rule

View EO 12866 Meetings Printer-Friendly Version     Download RIN Data in XML
DOJ/DEA RIN: 1117-AB51 Publication ID: Spring 2020 
Title: Registration and Reregistration Fees for Controlled Substance and List I Chemical Registrants 
Abstract:

DEA proposes adjusting the fee schedule for DEA registration and reregistration fees necessary to recover the costs of its Diversion Control Program relating to the registration and control of the manufacture, distribution, dispensing, importation and exportation of controlled substances and List I chemicals as mandated by the Controlled Substances Act.

 
Agency: Department of Justice(DOJ)  Priority: Economically Significant 
RIN Status: Previously published in the Unified Agenda Agenda Stage of Rulemaking: Proposed Rule Stage 
Major: Yes  Unfunded Mandates: No 
EO 13771 Designation: Other 
CFR Citation: 21 CFR 1301.13    21 CFR 1309.11    21 CFR 1309.21   
Legal Authority: 21 U.S.C. 821    21 U.S.C. 886a    21 U.S.C. 958(f)   
Legal Deadline:  None
Timetable:
Action Date FR Cite
NPRM  03/16/2020  85 FR 14810   
NPRM Comment Period End  05/15/2020 
Final Action  09/00/2020 
Regulatory Flexibility Analysis Required: No  Government Levels Affected: None 
Small Entities Affected: Businesses  Federalism: No 
Included in the Regulatory Plan: No 
RIN Data Printed in the FR: No 
Agency Contact:
Scott A. Brinks
Section Chief, Regulatory Drafting and Support Section, Diversion Control Division
Department of Justice
Drug Enforcement Administration
8701 Morrissette Drive,
Springfield, VA 22152
Phone:571 362-8209
Email: scott.a.brinks@dea.gov